HomeStock SectorsEnergy StocksCeasefire Cools Risk Premium...

Ceasefire Cools Risk Premium in Oil and Gold, but Supply Risks Remain

prices are edging higher this morning following a two-day decline, as the market evaluates the easing tensions in the Middle East. prices have fallen as the Iran-Israel ceasefire is reducing safe-haven demand

Energy – Oil Edges Higher After Two-day Drop on Ceasefire Deal

Oil prices rose this morning after a two-day decline, following US President Donald Trump’s statement expressing his desire to maintain the flow of oil from Iran. His comments came after he declared a ceasefire between Iran and Israel, following US airstrikes on Iran’s nuclear facilities.

In a Truth Social post, Trump said that China can continue to buy Iranian oil and that he hopes that the country will also be buying “plenty” from the US as well. However, a senior White House official later signalled that curbs on Iran would remain.

WTI crude is above $65 a barrel, while is trading near $68 this morning, after slumping 13% over the past two days. The Brent time spread has softened from a peak of $1.77 per barrel in backwardation last Thursday to approximately $1 per barrel this morning.

However, this figure remains elevated compared to the first five months of the year, where it fluctuated around $0.25-0.50 per barrel.

While concerns regarding Middle Eastern supply have diminished for now, they have not entirely disappeared, and there remains a stronger demand for immediate supply. The conflict in the Middle East hasn’t had any significant impact on oil flows from the Persian Gulf so far. Meanwhile, exports from Iran have surged.

OPEC+ is due to hold a video conference on 6 July to consider a further supply boost in August.

In the United States, the American Petroleum Institute (API) reported a decrease in crude oil inventories by 4.28 million barrels over the past week, which is significantly above the anticipated decrease of around 0.6 million barrels. In terms of refined products, gasoline inventories rose by 0.8 million barrels, while distillate inventories fell by 1.03 million barrels.

Metals – LME Copper Squeeze

continues to rise on the LME for a fourth day as tight supply remains in focus. Contracts for immediate delivery surged to a premium of $379/t to three-month futures on Monday, although it has since eased to around $150/t. This level is substantially higher than the near-zero premiums seen in May 2025 and a contango of approximately $100/t at the start of the year.

This tightening in the copper market follows a significant decline in inventories, which has dropped by roughly 176kt since the start of the year, now standing at just 95kt as of Tuesday, coupled with a tight supply in the concentrate market.

In precious metals, gold prices fell yesterday by more than 1% to $3,324/oz as both Israel and Iran reportedly upheld the ceasefire agreement after some earlier confusion and the intervention of the US president. also performed weakly as broader economic sentiment improved.

Additional pressure on gold prices also stems from expectations that Fed Chair Jerome Powell may not be in a hurry to implement further , considering inflation continues to exceed long-term targets and the Fed is observing the unfolding impact of import tariffs.

Disclaimer: This publication has been prepared by ING solely for information purposes irrespective of a particular user’s means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Read more

Original Post

Most Popular

More from Author

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline...

Read Now

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...

Oil Prices Expected to Stay Under $70

Analysts widely expect oil prices to remain below $70 per barrel for the remainder of 2025, primarily due to global oversupply and ongoing uncertainties regarding demand. Despite heightened geopolitical tensions in the Middle East, these factors are not anticipated to significantly drive up oil prices unless direct supply...